PEN
Penumbra
October 22, 2026 · after-hours
- Rarity
- 1.75
- Peak move
- +1.50%
- Float cap
- —
Penumbra is a medical device company that designs, manufactures, and markets thrombectomy, embolization, and vascular access products for specialist physicians. Its computer-assisted vacuum thrombectomy systems and neurovascular tools treat blood clots and aneurysms in conditions such as ischemic stroke, pulmonary embolism, deep vein thrombosis, and acute limb ischemia. It sells directly to hospitals and clinics in the United States, Europe, Canada, Australia, and Singapore, and through distributors elsewhere.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.